XYL
33
-2
AIG
45
-12
XEL
79
5
VIX
38
-3
CMG
41
3
MS
61
2
PNC
59
3
HOG
48
3
PBI
42
-4
PM
41
2
KMB
42
-2
PGR
40
3
MO
45
-2
HIG
54
-8
PEP
56
3
CNX
48
4
AES
46
2
SPG
30
3
HP
36
2
L
67
3
XYL
33
-2
AIG
45
-12
XEL
79
5
VIX
38
-3
CMG
41
3
MS
61
2
PNC
59
3
HOG
48
3
PBI
42
-4
PM
41
2
KMB
42
-2
PGR
40
3
MO
45
-2
HIG
54
-8
PEP
56
3
CNX
48
4
AES
46
2
SPG
30
3
HP
36
2
L
67
3
Financhill
Back

PIMCO Enhanced Low Duration Active Exchange-Traded Vs. Celldex Therapeutics, Inc. Industry Stock Comparison

Sell
32

LDUR
PIMCO Enhanced Low Duration Active Exchange-Traded

Last Price:
$95.47
Seasonality Move:
0.53%
Sell
48

CLDX
Celldex Therapeutics, Inc.

Last Price:
$31.05
Seasonality Move:
20.93%
Sell
32
PIMCO Enhanced Low Duration Active Exchange-Traded (LDUR) is a Sell

Is PIMCO Enhanced Low Duration Active Exchange-Traded a Buy, Sell or Hold?

  • The current PIMCO Enhanced Low Duration Active Exchange-Traded [LDUR] share price is $95.46. The Score for LDUR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • LDUR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Celldex Therapeutics, Inc. (CLDX) is a Sell

Is Celldex Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Celldex Therapeutics, Inc. [CLDX] share price is $31.05. The Score for CLDX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CLDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LDUR Stock Price Chart

What is PIMCO Enhanced Low Duration Active Exchange-Traded's stock price today?

  • The PIMCO Enhanced Low Duration Active Exchange-Traded share price today is $95.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LDUR is experiencing selling pressure, which indicates risk of future bearish movement.

CLDX Stock Price Chart

What is Celldex Therapeutics, Inc.'s stock price today?

  • The Celldex Therapeutics, Inc. share price today is $31.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDX is experiencing buying pressure, which is a positive indicator for future bullish movement.

LDUR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 43.32 Sell
Chaikin Money Flow: -85626 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (95.47 - 95.93) Sell
Bollinger Bands (100): (95.75 - 96.23) Sell

CLDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.9 Buy
Relative Strength Index (14 RSI): 55.97 Buy
Chaikin Money Flow: 3988094 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.43 - 31.31) Buy
Bollinger Bands (100): (24.48 - 29.54) Buy

LDUR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 95.53 Sell
20-day SMA: 95.63 Sell
50-day SMA: 95.94 Sell
200-day SMA: 95.91 Sell
8-day EMA: 95.55 Sell
20-day EMA: 95.66 Sell
50-day EMA: 95.84 Sell
200-day EMA: 95.86 Sell

CLDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.05 Buy
20-day SMA: 30.57 Buy
50-day SMA: 27.66 Buy
200-day SMA: 25.4 Buy
8-day EMA: 30.94 Buy
20-day EMA: 30.26 Buy
50-day EMA: 28.67 Buy
200-day EMA: 26.26 Buy

PIMCO Enhanced Low Duration Active Exchange-Traded Earnings Growth & LDUR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Celldex Therapeutics, Inc. Earnings Growth & CLDX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.20 per share, a decrease this year of $1.19 per share, and an increase next year of $0.04 per share.

PIMCO Enhanced Low Duration Active Exchange-Traded Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Celldex Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):